![Bent Hygum](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Bent Hygum worked as a Principal at Novo Nordisk A, Vice President-Quality at AGC Biologics A, and Senior Manager-Quality Assurance at Novozymes Biopharma.
DK A.
He holds a doctorate degree from Roskilde University, which he received in 2001.
Precedenti posizioni note di Bent Hygum
Società | Posizione | Fine |
---|---|---|
Novozymes Biopharma DK A/S
![]() Novozymes Biopharma DK A/S Pharmaceuticals: MajorHealth Technology Novozymes Biopharma DK A/S engages in the wholesale of pharmaceuticals and medical article. The firm operates and invests in research, development, production, and trade in biological solutions, including pharmaceuticals, and biotechnology products and processes.The company was founded on May 29, 2006 and is headquartered in Bagsvaerd, Denmark. | Corporate Officer/Principal | - |
NOVO NORDISK A/S | Corporate Officer/Principal | - |
AGC Biologics A/S
![]() AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Corporate Officer/Principal | - |
Formazione di Bent Hygum
Roskilde University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NOVO NORDISK A/S | Health Technology |
Aziende private | 2 |
---|---|
AGC Biologics A/S
![]() AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Health Technology |
Novozymes Biopharma DK A/S
![]() Novozymes Biopharma DK A/S Pharmaceuticals: MajorHealth Technology Novozymes Biopharma DK A/S engages in the wholesale of pharmaceuticals and medical article. The firm operates and invests in research, development, production, and trade in biological solutions, including pharmaceuticals, and biotechnology products and processes.The company was founded on May 29, 2006 and is headquartered in Bagsvaerd, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Bent Hygum